paxilline has been researched along with Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodská, B; Elknerová, K; Grebenová, D; Hrkal, Z; Kuzelová, K; Otevrelová, P; Pluskalová, M | 1 |
| Baron, S; Cohen, N; Geiger, B; Katz, BZ; Nadav, L; Naparstek, E | 1 |
| Binet, F; Chiasson, S; Girard, D; Lavastre, V; Moisan, E | 1 |
3 other study(ies) available for paxilline and Leukemia
| Article | Year |
|---|---|
Suberoylanilide hydroxamic acid (SAHA) at subtoxic concentrations increases the adhesivity of human leukemic cells to fibronectin.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Separation; Fibronectins; Flow Cytometry; Humans; Hydroxamic Acids; Integrin beta1; Leukemia; Lymphocytes; Paxillin; Reverse Transcriptase Polymerase Chain Reaction; Vorinostat | 2010 |
The generation and regulation of functional diversity of malignant plasma cells.
Topics: Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Genetic Variation; Humans; Integrins; Leukemia; Multiple Myeloma; Paxillin; Plasma Cells; Trinucleotide Repeats | 2006 |
Viscum album agglutinin-I induces degradation of cytoskeletal proteins in leukaemia PLB-985 cells differentiated toward neutrophils: cleavage of non-muscle myosin heavy chain-IIA by caspases.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Differentiation; Cell Line, Tumor; Cytoskeleton; Flow Cytometry; Humans; Lamin Type B; Leukemia; Neutrophils; Nonmuscle Myosin Type IIA; Paxillin; Plant Preparations; Plant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Ribosome Inactivating Proteins; Ribosome Inactivating Proteins, Type 2; RNA, Messenger; Toxins, Biological; Vimentin | 2007 |